Methylation and decreased expression of SHP-1 are related to disease progression in chronic myelogenous leukemia. [electronic resource]
Producer: 20150112Description: 2438-46 p. digitalISSN:- 1791-2431
- Adolescent
- Adult
- Aged
- Antineoplastic Agents -- pharmacology
- Benzamides -- pharmacology
- Cell Line, Tumor
- Child
- DNA Methylation -- genetics
- Disease Progression
- Female
- Fusion Proteins, bcr-abl -- biosynthesis
- Humans
- Imatinib Mesylate
- Janus Kinase 2 -- metabolism
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- pathology
- MAP Kinase Signaling System
- Male
- Middle Aged
- Mitogen-Activated Protein Kinases -- metabolism
- Piperazines -- pharmacology
- Promoter Regions, Genetic
- Protein Kinase Inhibitors -- pharmacology
- Protein Tyrosine Phosphatase, Non-Receptor Type 6 -- biosynthesis
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Proto-Oncogene Proteins c-akt -- metabolism
- Proto-Oncogene Proteins c-myc -- metabolism
- Pyrimidines -- pharmacology
- RNA, Messenger -- biosynthesis
- STAT5 Transcription Factor -- metabolism
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.